Novella ClinicalReferralGrown-1

Novella Clinical has experienced unbelievable growth and success since rebranding with R+M. They turned an internally branded division into a service offering and acquired a company in the UK to extend their global presence. Shortly after, they acquired two other companies to help fortify their offerings and now, as a Quintiles company, they have retained their brand equity and continue to deliver individual attention with global reach to customers all over the world.

In the world of clinical research organizations (CRO), everyone focuses on the obvious: experience, capabilities, speed to market. Novella promises more, and delivers. Individual attention, a collaborative approach and above all, helping their customers improve the human condition.

This message needed to be front and center, like the lives they help to improve. And, remain consistent as part of their brand promise.

Services We Delivered

Unique Value Proposition
Brand Architecture
Brand Guide + Identity Development
Employee Brand Alignment
Company + Product Naming
Merger + Acquisition Transition
Print + Digital Creative
Web Design + SEO
Trade Show + Event Marketing
Sales Collateral + Support
Media Planning + Placement

We developed their brand and unique value proposition (UVP) through our THIRST® process, and had a solid foundation to concept their brand name. Based off of the concepts of emergence and achievement, we highlighted their innovative roots, their customer’s innovative spirit, as well as their ability to support, guide and affect.

“Rebranding a company after 10 years of success is a delicate proposition. R+M did a great job of guiding us through the process. With their leadership we have a brand that accurately communicates who we are and positions us for growth.”

Richard Staub, Former President, Novella Clinical
Novella Clinical, website home page
Beautiful photography focuses on one person, which more emotionally connects with their customers.

The facing Ls from the logo further emphasize our commitment to the end result of improving lives.

Segmenting navigation, specific to therapeutic area, Oncology, Medical Device & Diagnostics, and Dermatology, emphasizes individual attention and unique focus. This further differentiates Novella Clinical from the competitors.

Novella Clinical Website portfolio sample graphic

“We selected R+M for our site redesign after a competitive review. Once again they demonstrated a thorough understanding of our business and delivered a site that rivals our competitors of any size.”

Jessica Cunningham, Senior Director, Marketing & Communication, Novella Clinical
The website is our top opportunity generator – downloads and web inquires generated more than 15% of new revenue opportunities.


As a successfully rebranded CRO, Novella Clinical has retained the equity and customer base of the acquired brands and has continued growth year upon year. Celebrating their 20th year in business, Novella has solidified their position in the marketplace as a leading CRO.

Advancing Trials. Improving Lives. 

Novell Clinical was acquired by Quintiles (now IQVIA) in 2013, retaining 100% of their brand recognition and operating independently.

For six more years Novella gained strength and expertise serving the biotech market and we relaunched their brand in 2019 as IQVIA Biotech, a full-service CRO, still operating independently and exclusively serving biotech.

We are proud to continue this amazing partnership and support their brand needs through 2024 and beyond.

Don’t Just Be Unique

R+M is a brand experience agency focused on companies that positively impact how we live, strengthened by our center of excellence on high-growth brands in transition.